Faculty profile

David Rush

ResearcherMedicine/NephrologyUniversity of Manitoba

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Manitoba directory, so their courses and email address may be missing. Find their university profile.

David Rush

Researcher

Medicine/Nephrology

Health Sciences

University of Manitoba

Winnipeg, Manitoba, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
4 publications in the last five years, latest in 2026.
Principal investigator on 2 research grants (2 CIHR), most recently in 2016.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Ccl2 Chemokines Cxcl10 Cxcl9 Graft Failure Randomized Controlled Effectiveness Trial Rejection Renal Transplant

Latest papers

Conference Report-The Past, Current, and Future Challenges in Transplantation: A Festschrift in Honor of Professor Paul Anthony Keown.
Canadian journal of kidney health and disease · 2026
The Evolution of Molecular Phenotypes Through Time in Kidney Transplant Recipients.
Transplantation direct · 2026
[Cellular rejection in kidney transplant. Results of a national survey in Argentina].
Medicina · 2026

All 28 publications

Latest funding

Multi-center validation of non-invasive biomarkers of renal allograft outcomes
CIHR · 2019 · Co-investigator
$237,151
A randomized controlled effectiveness trial of urine CXCL10 chemokine monitoring post-renal transplant
CIHR · 2016 · Principal investigator
$2,664,284
Chronic Antibody Mediated Rejection: Identification of mechanisms and diagnostic proteins
CIHR · 2013 · Co-investigator
$804,160

All 6 grants and awards

28 publications.

Conference Report-The Past, Current, and Future Challenges in Transplantation: A Festschrift in Honor of Professor Paul Anthony Keown.

Gill J, Stiller C, Lan J, Jevnikar A, Halloran PF, Rush D, Nickerson P, Cole E, Matas AJ, Formica R, Sawinski D, Blosser CD, Mannon RB, Keown PA

Canadian journal of kidney health and disease2026

DOI: 10.1177/20543581261434082 PMID: 42063677

The Evolution of Molecular Phenotypes Through Time in Kidney Transplant Recipients.

Baragar B, Adam BA, Mengel M, Balshaw R, Gibson IW, Ho J, Shaw J, Karpinski M, Trachtenberg A, Pochinco D, Goldberg A, Birk P, Pinsk M, Rush D, Nickerson PW, Wiebe C

Transplantation direct2026

DOI: 10.1097/txd.0000000000001919 PMID: 41884703

[Cellular rejection in kidney transplant. Results of a national survey in Argentina].

Caldano J, Rush D, Giordani MC, Benitez ML, Osella F, Reinoso S, Gómez MD, De La Fuente JL, Barrera G, Sleiman J

Medicina2026

PMID: 42330384

Risk Prediction for Delayed Allograft Function: Analysis of the Deterioration of Kidney Allograft Function (DeKAF) Study Data.

Matas AJ, Helgeson E, Fieberg A, Leduc R, Gaston RS, Kasiske BL, Rush D, Hunsicker L, Cosio F, Grande JP, Cecka JM, Connett J, Mannon RB

Transplantation2022

DOI: 10.1097/tp.0000000000003718 PMID: 33675321

Novel Phenotypes for Acute Kidney Transplant Rejection Using Semi-Supervised Clustering.

Matas AJ, Mannon RB, Rush D, Helgeson E

Journal of the American Society of Nephrology : JASN2021

DOI: 10.1681/asn.2021040572 PMID: 34403355

i-IFTA and chronic active T cell-mediated rejection: A tale of 2 (DeKAF) cohorts.

Helgeson ES, Mannon R, Grande J, Gaston RS, Cecka MJ, Kasiske BL, Rush D, Gourishankar S, Cosio F, Hunsicker L, Connett J, Matas AJ

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2021

DOI: 10.1111/ajt.16352 PMID: 33052625

Validity and utility of urinary CXCL10/Cr immune monitoring in pediatric kidney transplant recipients.

Blydt-Hansen TD, Sharma A, Gibson IW, Wiebe C, Sharma AP, Langlois V, Teoh CW, Rush D, Nickerson P, Wishart D, Ho J

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2021

DOI: 10.1111/ajt.16336 PMID: 33034126

Early surveillance biopsy utilization and management of pediatric renal allograft acute T cell-mediated rejection in Canadian centers: Observations from the PROBE multicenter cohort study.

Hoffmann AJ, Gibson IW, Ho J, Nickerson P, Rush D, Sharma A, Wishart D, Blydt-Hansen TD

Pediatric transplantation2021

DOI: 10.1111/petr.13870 PMID: 33026135

Inflammation in areas of fibrosis: The DeKAF prospective cohort.

Matas AJ, Helgeson ES, Gaston R, Cosio F, Mannon R, Kasiske BL, Hunsicker L, Gourishankar S, Rush D, Michael Cecka J, Connett J, Grande JP

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2020

DOI: 10.1111/ajt.15862 PMID: 32185865

Late Graft Loss After Kidney Transplantation: Is "Death With Function" Really Death With a Functioning Allograft?

Gaston RS, Fieberg A, Helgeson ES, Eversull J, Hunsicker L, Kasiske BL, Leduc R, Rush D, Matas AJ, DeKAF Investigators*

Transplantation2020

DOI: 10.1097/tp.0000000000002961 PMID: 31568212

Multi-center validation of non-invasive biomarkers of renal allograft outcomes

Co-investigatorCIHR2019Project Grant

Principal investigators: Ho, Julie

Keywords: Ccl2; Chemokine; Cxcl10; Graft Loss; Kidney Transplant Outcome; Multi-Center Prospective Observational Cohort; Prognostic Marker; Transplant Histology; Urine Biomarker; Validation Study

$237,151

A randomized controlled effectiveness trial of urine CXCL10 chemokine monitoring post-renal transplant

Principal investigatorCIHR2016Project Grant

Principal investigators: Ho, Julie; Gibson, Ian W; Hirt-Minkowski, Patricia; Nickerson, Peter W; Rush, David N; Sharma, Atul K; Wiebe, Chris J

Keywords: Ccl2; Chemokines; Cxcl10; Cxcl9; Graft Failure; Randomized Controlled Effectiveness Trial; Rejection; Renal Transplant; Urine Diagnostic Biomarker; Urine Prognostic Biomarker

$2,664,284

Chronic Antibody Mediated Rejection: Identification of mechanisms and diagnostic proteins

Co-investigatorCIHR2013Operating Grant

Principal investigators: Nickerson, Peter W

Keywords: Antibody Mediated Rejection; Biomarkers; Chemokines; Proteomics; Transplantation

$804,160

Identification of novel proteins as diagnostic or mechanistic targets for renal allograft inflammation.

Principal investigatorCIHR2012Operating Grant

Principal investigators: Ho, Julie; Gibson, Ian W; Nickerson, Peter W; Rigatto, Claudio; Rush, David N; Wilkins, John A

Keywords: Activity-Based Protein Profiling; Acute Kidney Injury; Catabolomics; Interstitial Fibrosis/Tubular Atrophy & Inflammation; Ischemia Reperfusion Injury; Proteomics; Renal Transplantation; Selected Reaction Monitoring Mass Spectrometry; Subclinical And Clinical Rejection; Urine Biomarker

$854,358

The Canadian National Transplant Research Program: Increasing Donation and Improving Transplantation Outcomes

Co-investigatorCIHR2012Transplantation Research - Full Application

Principal investigators: West, Lori J; Caulfield, Timothy A; Hébert, Marie-Josée; Humar, Atul; Knoll, Gregory; Levings, Megan K; Mital, Seema; Roy, Denis-Claude; Schultz, Kirk R; Shapiro, James

Keywords: Bone Marrow; Increasing Donation; Inflammation; Organ Repair; Pediatrics; Solid Organs/Cells; Stem Cells; Tolerance/Immunomodulation; Transplant Complications; Transplantation

$11,250,000

The BK: KIDNI Trial (BK: Kinase Inhibition to Decrease Nephropathy Intervention Trial)

Co-investigatorCIHR2009Randomized Controlled Trials

Principal investigators: Tibbles, Lee Anne; Hemmelgarn, Brenda R; Manns, Braden J

Keywords: Bk Virus; Chronic Allograft Nephropathy; Inflammation And Fibrosis; Randomized Controlled Clinical Trial; Sirolimus And Leflunomide; Transplant Failure

$3,319,686

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

David Rush

Research

Latest papers

Latest funding

Conference Report-The Past, Current, and Future Challenges in Transplantation: A Festschrift in Honor of Professor Paul Anthony Keown.

The Evolution of Molecular Phenotypes Through Time in Kidney Transplant Recipients.

[Cellular rejection in kidney transplant. Results of a national survey in Argentina].

Risk Prediction for Delayed Allograft Function: Analysis of the Deterioration of Kidney Allograft Function (DeKAF) Study Data.

Novel Phenotypes for Acute Kidney Transplant Rejection Using Semi-Supervised Clustering.

i-IFTA and chronic active T cell-mediated rejection: A tale of 2 (DeKAF) cohorts.

Validity and utility of urinary CXCL10/Cr immune monitoring in pediatric kidney transplant recipients.

Early surveillance biopsy utilization and management of pediatric renal allograft acute T cell-mediated rejection in Canadian centers: Observations from the PROBE multicenter cohort study.

Inflammation in areas of fibrosis: The DeKAF prospective cohort.

Late Graft Loss After Kidney Transplantation: Is "Death With Function" Really Death With a Functioning Allograft?

Multi-center validation of non-invasive biomarkers of renal allograft outcomes

A randomized controlled effectiveness trial of urine CXCL10 chemokine monitoring post-renal transplant

Chronic Antibody Mediated Rejection: Identification of mechanisms and diagnostic proteins

Identification of novel proteins as diagnostic or mechanistic targets for renal allograft inflammation.

The Canadian National Transplant Research Program: Increasing Donation and Improving Transplantation Outcomes

The BK: KIDNI Trial (BK: Kinase Inhibition to Decrease Nephropathy Intervention Trial)

Frequent collaborators

Peter Nickerson

Julie Ho

Atul Sharma

Chris Wiebe

David Wishart

Claudio Rigatto

Paul Komenda

Anthony Jevnikar

Julie Ho

Navdeep Tangri

James Lan

John Gill

Kent Hayglass